Society | Society : | Sustainability | ONO PHARMACEUTICAL CO., LTD.

Investors
News
Contact

Japanese
Global

About
About
Company Profile

Management

Business Locations

ONO Story
R＆D

Manufacturing

Marketing

Safety and Quality Assurance

Digital & IT
ONO’s 300-Year History
CLOSE

ONO Story

Videos and Advertisements
R＆D
R＆D
CLOSE

Development Pipeline
Global Business
Sustainability
Sustainability
Corporate Governance

Compliance

Risk Management

Responsible Promotion Activities
Innovative Pharmaceutical Products

Efforts Made for Improving Access to Healthcare

Respect for Human Rights

Expansion of Human Capital (Talent Development and Employment)

Expansion of Human Capital (Fostering an Organizational Climate and Culture that realizes high employee engagement)

Expansion of Human Capital (Health Management)

Sustainable Procurement
Commitment to Conservation of the Global Environment

Information Disclosure Based on the TCFD Recommendation

Realization of a Decarbonized Society

Realization of a Water Recycling Society

Realization of a Resource Recycling Society

Information Disclosure Based on the TNFD Recommendations

Biodiversity

EHS Management

Environmental Accounting
Stakeholder Engagement

Dialogue with Shareholders and Investors

Cooperation with Governments
ONO’s Social Contribution Activities Global Policy

Efforts for the Advancement of Medicine and Pharmacy

Efforts for Supporting Health of Patients and Their Families

Efforts Toward Environmental Conservation for the Health of Everyone

Efforts Toward an Education for the Children’s Health

Efforts for Improvement of the Medical Ecosystem
CLOSE

ECO VISION 2050

Improving Access to Healthcare

About
Business Activities
R＆D
Global Business
- Global Business Top
Sustainability

Society :

Society

Innovative Pharmaceutical Products

Innovative Pharmaceutical Products
Efforts Made for Improving Access to Healthcare

Basic Policy

Examples of Innovative pharmaceutical products R & D Initiatives

Efforts to Strengthen the Medical Environment –Capacity Building–

Participation in Access Accelerated Initiatives

Respect for Human Rights

Basic Policy for Human Rights

Human Rights Due Diligence

Access to Relief and Response to Violations and Corrective Actions
Expansion of Human Capital (Talent Development and Employment)

Growth Strategy and Talent Strategy Towards Achievement of Corporate Philosophy

Desired Talents

Training " Versatile Human Resources " that Supports the Management Foundation Inter-departmentally

Employment and Training " Professional Human Resources " that Promote Our Growth Strategy

Improving the Capabilities of Our Talent

Education and Training Programs for Talent Development

Employment of Talent

Expansion of Human Capital (Fostering an Organizational Climate and Culture that realizes high employee engagement)

DE&I Initiatives (Promotion of diverse human resources)

Other Initiatives related to DE&I

Introduction of the Global HR System

Efforts made regarding wages

Relationship with the Labor Unions
Expansion of Human Capital (Health Management)

Efforts made to promote employees’ health

Organizational structure to promote health management

Sustainable Procurement

Our Stance on Supply Chain Management

Joining the PSCI (Pharmaceutical Supply Chain Initiative)

Declaration on Partnership Formation

Anti-bribery due diligence for third parties

Animal experiment outsourcing policy

ONO PHARMACEUTICAL CO.,LTD., ONO PHARMACEUTICAL CO.,LTD., system

Official Channel

About

About
R＆D

R＆D
Global Business

Global Business
Sustainability

Sustainability

Investors
News
Contact

Japanese
Global

Privacy Policy
Terms of Use
Site Map

Official Channel

COPYRIGHT © 2022 ONO PHARMACEUTICAL CO., LTD.
ALL RIGHTS RESERVED.